Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death - Nested Case Control Analyses in a Cohort of First-time Users of Low Dose ASA for Secondary Prevention of Cerebrovascular and Cardiovascular Outcomes.

NCT01360047 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01360047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01360047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death - Nested Case Control Analyses in a Cohort of First-time Users of Low Dose ASA for Secondary Prevention of Cerebrovascular and Cardiovascular Outcomes.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2011
Enrollment
39,513 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary death, nonfatal myocardial infarction